Bluelinx Holdings (BXC) Reports In-Line Q4 Loss
Tweet
Share
E-mailGet Alerts BXC Hot Sheet
Price: $81.81 --0%
Revenue Growth %: +8.6%
Financial Fact:
Depreciation and amortization: 2.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +8.6%
Financial Fact:
Depreciation and amortization: 2.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bluelinx Holdings (NYSE: BXC) reported Q4 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $454.1 million versus the consensus estimate of $486.3 million.
For earnings history and earnings-related data on Bluelinx Holdings (BXC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
- Morgan Stanley Downgrades Infineon Technologies (IFX:GY) (IFNNY) to Equalweight
- Evercore ISI on Jersey Mike's Subs (JMKE): 'Anticipating a positive outlook'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
